Juan L. Ngadio
Pulomas, JK 13210, Indonesia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comprehensive In Silico Investigation of L-Glutamine Transporters and Metabolism in Glioblastoma.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 19, 2026
Integrative Multi-Omics and Single-Cell Profiling Identify Chitinase Domain Containing Protein 1 (CHID1) as a Prognostic Biomarker in Glioblastoma.
Journal: Journal of Cancer
Published: December 24, 2025
Single-cell transcriptomics reveal PRRC1 as a malignant cell enriched driver of DNA repair and therapy resistance in glioblastoma.
Journal: DNA repair
Published: October 25, 2025
Multi-Omics and Single-Cell Dissection of Exostosin Glycosyltransferases (EXT1/EXT2) Reveals Divergent Oncogenic Roles and Therapeutic Vulnerabilities in Gliomas.
Journal: Journal of Cancer
Published: August 19, 2025
Targeting ORMDL2 in glioblastoma through integrated landscape of high-throughput sequencing and pharmacogenomic analysis.
Journal: International journal of medical sciences
Published: May 05, 2025
Metal ion transporter SLC39A14-mediated ferroptosis and glycosylation modulate the tumor immune microenvironment: pan-cancer multi-omics exploration of therapeutic potential.
Journal: Cancer cell international
Published: April 06, 2025
Multi-omics profiling reveals PLEKHA6 as a modulator of β-catenin signaling and therapeutic vulnerability in lung adenocarcinoma.
Journal: American journal of cancer research
Published: December 09, 2024
Integration of multi-omics and single-cell transcriptome reveals mitochondrial outer membrane protein-2 (MTX-2) as a prognostic biomarker and characterizes ubiquinone metabolism in lung adenocarcinoma.
Journal: Journal of Cancer
Published: November 13, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026